REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/13/2025
Back to search
Official data from USPTO
KINTOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
10/14/2025
Trademark type
Combined
Nice classes
5, 35, 42, 44
Filing date
09/20/2018
Registration date
10/13/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/13/2020
Last transaction
10/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
SUZHOU CITY, JIANGSU PROVINCE, CN
Examiner
LAPTER,ALAIN J
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "KINTOR"; the letter "O" of the word "KINTOR" contains four white Chinese characters on a black background.
Holders and representatives
Holders
SUZHOU KINTOR PHARMACEUTICALS, INC.
Kintor Pharmaceutical Limited
Representatives
Alex Patel Patel IP, P.C.
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for treatment of cancer; sachets for pharmaceutical purposesmedicines in the form of capsuleschemico-pharmaceutical preparationsdrugs for medical purposeschemical preparations for pharmaceutical purposesbiological preparations for medical purposeschemical preparations for medical purposesall of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the preventiondiagnosistreatment and adjunctive therapy of cancercardiovascular diseasenervous system diseasesinfectious diseasesrespiratory diseasesendocrine and metabolic diseasesmental disorderskin diseasediseases of the blood systemdigestive system diseasesimmune system diseasesdiseases of genitourinary systemocular diseasesotolaryngology and dentistry diseasesmusculoskeletal and connective tissue diseasesnutritional diseasesdiseases caused by external factorspoisoning and injury; compounds for treating cancer; pharmaceuticalsmedical and veterinary preparations for the preventiondiagnosistreatment and adjunctive therapy of cancercardiovascular diseasenervous system diseasesinfectious diseasesrespiratory diseasesendocrine and metabolic diseasesmental disorderskin diseasediseases of the blood systemdigestive system diseasesimmune system diseasesdiseases of genitourinary systemocular diseasesotolaryngology and dentistry diseasesmusculoskeletal and connective tissue diseasesnutritional diseasesdiseases caused by external factorspoisoning and injury; sanitary preparations for medical purposes; dietetic food and substancesdietetic foodssugar substitutesnutritional beveragesdietary supplements for weight loss adapted for medical and veterinary use; food for babies; dietary supplements for humans and animals; plasters and materialsgauze for medical dressings; materials for dental fillings and for sealing purposes; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides
Class 35
Retail pharmacy services; advertising services; business management; business administration services; providing office functions; informationadvisory and consultancy services relating to all the aforesaid services
Class 42
Scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating theretoconsulting and advisory servicesCRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; industrial analysis and research services in the field of pharmaceuticals; design and development of computer hardware and software; informationadvisory and consultancy services relating to all the aforesaid services
Class 44
Pharmaceutical compounding services; providing medical information and information relating to the diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical advice in the field of medicinepharmacologymedical analysis and diagnostics; provision of medical services in the field of alternative medicine; providing medical information relating to medicinepharmacology and medical diagnosis; medicine and treatment prescription servicesservices relating to the diagnosis of illness and prescription of medicine; medicine and treatment prescription serviceshome health care servicesmanaged health care services; physical therapy services; medical diagnostic testingmonitoring and reporting services; medical services; veterinary services; hygienic and beauty salon and consultation services for human beings and animals; medicine and treatment prescription servicesinsecticide sprayingvermin extermination for agriculturehorticulture and forestry; informationadvisory and consultancy services relating to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
39 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/07/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/23/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/13/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
09/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/04/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/10/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
07/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/09/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
02/14/2020
APET
ASSIGNED TO PETITION STAFF
02/12/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/21/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2019
PUBO
PUBLISHED FOR OPPOSITION
11/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/15/2019
ALIE
ASSIGNED TO LIE
10/14/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/09/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/13/2019
GNSL
LETTER OF SUSPENSION E-MAILED
07/13/2019
CNSL
SUSPENSION LETTER WRITTEN
07/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2019
GNRT
NON-FINAL ACTION E-MAILED
01/07/2019
CNRT
NON-FINAL ACTION WRITTEN
01/07/2019
DOCK
ASSIGNED TO EXAMINER
01/02/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2018
NWAP
NEW APPLICATION ENTERED
09/24/2018
Continuous trademark protection
Get notified about every new filing that threatens KINTOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.